First Time Loading...

Demant A/S
CSE:DEMANT

Watchlist Manager
Demant A/S Logo
Demant A/S
CSE:DEMANT
Watchlist
Price: 326 DKK 0.74% Market Closed
Updated: Jun 5, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Demant A/S

Revenue
22.4B DKK
Cost of Revenue
-5.9B DKK
Gross Profit
16.5B DKK
Operating Expenses
-12.5B DKK
Operating Income
4.1B DKK
Other Expenses
-2.3B DKK
Net Income
1.8B DKK

Margins Comparison
Demant A/S Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DK
Demant A/S
CSE:DEMANT
71.9B DKK
74%
18%
8%
US
Shockwave Medical Inc
NASDAQ:SWAV
12.2B USD
87%
20%
21%
US
Abbott Laboratories
NYSE:ABT
178B USD
55%
16%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
147.4B USD
66%
25%
27%
US
Stryker Corp
NYSE:SYK
131.3B USD
64%
21%
16%
US
Boston Scientific Corp
NYSE:BSX
111.2B USD
69%
17%
12%
IE
Medtronic PLC
NYSE:MDT
107.5B USD
66%
20%
11%
US
Becton Dickinson and Co
NYSE:BDX
68.5B USD
41%
11%
7%
DE
Siemens Healthineers AG
XETRA:SHL
61B EUR
38%
12%
8%
US
Edwards Lifesciences Corp
NYSE:EW
52.3B USD
77%
29%
23%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368B CNY
65%
35%
34%
Country DK
Market Cap 71.9B DKK
Gross Margin
74%
Operating Margin
18%
Net Margin
8%
Country US
Market Cap 12.2B USD
Gross Margin
87%
Operating Margin
20%
Net Margin
21%
Country US
Market Cap 178B USD
Gross Margin
55%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 147.4B USD
Gross Margin
66%
Operating Margin
25%
Net Margin
27%
Country US
Market Cap 131.3B USD
Gross Margin
64%
Operating Margin
21%
Net Margin
16%
Country US
Market Cap 111.2B USD
Gross Margin
69%
Operating Margin
17%
Net Margin
12%
Country IE
Market Cap 107.5B USD
Gross Margin
66%
Operating Margin
20%
Net Margin
11%
Country US
Market Cap 68.5B USD
Gross Margin
41%
Operating Margin
11%
Net Margin
7%
Country DE
Market Cap 61B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country US
Market Cap 52.3B USD
Gross Margin
77%
Operating Margin
29%
Net Margin
23%
Country CN
Market Cap 368B CNY
Gross Margin
65%
Operating Margin
35%
Net Margin
34%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Demant A/S Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DK
Demant A/S
CSE:DEMANT
71.9B DKK
20%
6%
20%
11%
US
Shockwave Medical Inc
NASDAQ:SWAV
12.2B USD
25%
13%
15%
30%
US
Abbott Laboratories
NYSE:ABT
178B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
147.4B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
131.3B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
111.2B USD
9%
5%
8%
6%
IE
Medtronic PLC
NYSE:MDT
107.5B USD
7%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
68.5B USD
5%
2%
5%
4%
DE
Siemens Healthineers AG
XETRA:SHL
61B EUR
10%
4%
8%
5%
US
Edwards Lifesciences Corp
NYSE:EW
52.3B USD
22%
15%
22%
22%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368B CNY
36%
25%
34%
46%
Country DK
Market Cap 71.9B DKK
ROE
20%
ROA
6%
ROCE
20%
ROIC
11%
Country US
Market Cap 12.2B USD
ROE
25%
ROA
13%
ROCE
15%
ROIC
30%
Country US
Market Cap 178B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 147.4B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 131.3B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 111.2B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
6%
Country IE
Market Cap 107.5B USD
ROE
7%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 68.5B USD
ROE
5%
ROA
2%
ROCE
5%
ROIC
4%
Country DE
Market Cap 61B EUR
ROE
10%
ROA
4%
ROCE
8%
ROIC
5%
Country US
Market Cap 52.3B USD
ROE
22%
ROA
15%
ROCE
22%
ROIC
22%
Country CN
Market Cap 368B CNY
ROE
36%
ROA
25%
ROCE
34%
ROIC
46%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More